7947725

Cases: 4
Active: 0; 4 closed
Filed: 2011–2016
Top venue: D. New Jersey; 2 cases

Filing activity

Cases asserting US Patent 7947725 filed per year.

Helsinn Healthcare S.A. et al. v. Dr. Reddy's Laboratories, Ltd. et al.

judgment (invalidated on appeal; Supreme Court affirmed)

Docket:: 3:11-cv-03962
Court:: U.S. District Court for the District of New Jersey
Filed:: 2011-07-08

π Helsinn Healthcare S.A.π Roche Palo Alto LLC Δ Dr. Reddy's Laboratories, Ltd.Δ Dr. Reddy's Laboratories, Inc.Δ Sandoz, Inc.Δ Teva Pharmaceuticals USA, Inc.Δ Teva Pharmaceutical Industries, Ltd.

Consolidated Hatch-Waxman ANDA action in D.N.J. (lead case 3:11-cv-03962, consolidated with 3:11-cv-05579 and 3:13-cv-05815) asserting the '724, '725, '424, and '219 patents. District court found claims valid and infringed, but the Federal Circuit reversed under the on-sale bar and the Supreme Court affirmed invalidity.

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.

reversed

Docket:: 16-1284
Court:: U.S. Court of Appeals for the Federal Circuit
Terminated:: 2017-05-01

Patents:7960424 7947724 7947725 8598219

π Helsinn Healthcare S.A.Δ Teva Pharmaceuticals USA, Inc.

Federal Circuit appeal of the D.N.J. consolidated action; reversed the district court and held asserted claims of the '724, '725, '424, and '219 patents invalid under the on-sale bar.

Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC

terminated

Docket:: 1:15-cv-00865
Court:: U.S. District Court for the District of Delaware
Filed:: 2015-09-24
Terminated:: 2015-12-02

Patents:7960424 7947724 7947725 8598219 8729094

π Helsinn Healthcare S.A.Δ Fresenius Kabi USA, LLC

Delaware Hatch-Waxman ANDA action asserting the '724, '725, '424, '219, and '094 patents against Fresenius Kabi USA, LLC; terminated in 2015.

Helsinn Healthcare S.A. v. Sagent Pharmaceuticals, Inc.

settled

Docket:: 3:16-cv-00173
Court:: U.S. District Court for the District of New Jersey
Filed:: 2016-01-11

Patents:7960424 7947724 7947725 8598219 8729094

π Helsinn Healthcare S.A.Δ Sagent Pharmaceuticals, Inc.

New Jersey Hatch-Waxman ANDA action (ANDA No. 205870) asserting the '724, '725, '424, '219, and '094 patents against Sagent Pharmaceuticals, Inc.; Sagent later settled.